Betta Pharmaceuticals Co., Ltd.
SZSE:300558.SZ
56.74 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Betta Pharmaceuticals Co., Ltd. |
Symbool | 300558.SZ |
Munteenheid | CNY |
Prijs | 56.19 |
Beurswaarde | 23,514,729,239 |
Dividendpercentage | 0.17% |
52-weken bereik | 42.5 - 74.83 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Lieming Ding |
Website | https://www.bettapharma.com |
An error occurred while fetching data.
Over Betta Pharmaceuticals Co., Ltd.
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)